Skip to content

Alumis Inc. ALMS Share Repurchase Liability

Share Repurchase Liability at other companies

MBX Biosciences, Inc. logo
MBX Biosciences, Inc.MBX
$1K-95.7%
PennyMac Financial Services, Inc. logo
PennyMac Financial Services, Inc.PFSI
$10.18B+44.2%
1st Source Corporation logo
1st Source CorporationSRCE
$50K-58.3%
Henry Schein logo
Henry ScheinHSIC
$250M
EFC
Ellington Financial Inc.EFC
$45.1M0.0%
Qualys, Inc. logo
Qualys, Inc.QLYS
$199.5K-0.5%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.17B+739%

Profitability

See full
Operating margin-5,364%
Net margin-2,825.7%
FCF margin-4,487.4%

Returns & leverage

See full
Return on equity-64.6%
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept alms:ShareRepurchaseLiability.

The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alumis Inc.'s share repurchase liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alumis Inc.'s share repurchase liability?
Alumis Inc. (ALMS) reported share repurchase liability of $94K in Q1 2026.
How has Alumis Inc.'s share repurchase liability changed year-over-year?
Alumis Inc.'s share repurchase liability decreased by 84.0% year-over-year, from $588K to $94K.
What is the long-term trend for Alumis Inc.'s share repurchase liability?
Over 2 years (2023 to 2025), Alumis Inc.'s share repurchase liability has grown at a -73.6% compound annual growth rate (CAGR), from $1.77M to $123K.
What does share repurchase liability mean?
This represents a financial obligation arising from a commitment to repurchase the company's own shares from the open market or specific shareholders. It indicates a planned return of capital to shareholders or the settlement of equity-based instruments. Monitoring this liability is essential for understanding the company's capital allocation strategy and its impact on future cash reserves.